首页> 外文期刊>Mutation Research: International Journal on Mutagenesis, Chromosome Breakage and Related Subjects >Mutation analyses of KRAS exon 1 comparing three different techniques: temporal temperature gradient electrophoresis, constant denaturant capillary electrophoresis and allele specific polymerase chain reaction.
【24h】

Mutation analyses of KRAS exon 1 comparing three different techniques: temporal temperature gradient electrophoresis, constant denaturant capillary electrophoresis and allele specific polymerase chain reaction.

机译:KRAS外显子1的突变分析比较了三种不同的技术:瞬时温度梯度电泳,恒定变性毛细管电泳和等位基因特异性聚合酶链反应。

获取原文
获取原文并翻译 | 示例
       

摘要

Mutations in the KRAS gene is a key event in the carcinogenesis of many human cancers and may serve as a diagnostic marker and a target for therapeutic intervention. In this study we have applied three different techniques for mutation detection of KRAS exon 1 mutations: Allele specific polymerase chain reaction (AS-PCR), temporal temperature gradient electrophoresis (TTGE) and constant denaturant capillary electrophoresis (CDCE). Samples from 191 sporadic colon carcinomas were analyzed. AS-PCR were performed with oligonucleotides specific for know mutations in codon 12 and 13 of the KRAS gene. In TTGE analyses, linear ramping of the temperature were performed during electrophoresis in a constant denaturant gel. CDCE analyses were performed using fluorescin labeled PCR-products. Separation was achieved under constant denaturing conditions using high temperature in a gel-filled capillary followed by laser detection. A mutated KRAS gene was found in 42/191 (22.0%) of the samples using AS-PCR, in 62/191 (32.5%) using TTGE and in 66/191 (34.6%) of the samples using CDCE. In the TTGE and CDCE analyses the sequence of the mutant were determined by comparing the electrophoretic pattern to that of known mutations or by mixing the sample with known mutations prior to reanalysis. In a titration experiment mixing mutant and wild-type alleles prior to PCR, the sensitivity for mutation detection was shown to be 10(-2) for TTGE and under optimized conditions 10(-3) for CDCE.
机译:KRAS基因中的突变是许多人类癌症发生中的关键事件,并且可以作为诊断标记和治疗干预的靶标。在这项研究中,我们将三种不同的技术用于KRAS外显子1突变的突变检测:等位基因特异性聚合酶链反应(AS-PCR),瞬时温度梯度电泳(TTGE)和恒定变性毛细管电泳(CDCE)。分析了191例散发性结肠癌的样本。用对KRAS基因密码子12和13的已知突变具有特异性的寡核苷酸进行AS-PCR。在TTGE分析中,在恒定变性凝胶中进行电泳时,温度会线性升高。使用荧光素标记的PCR产物进行CDCE分析。在恒定变性条件下,使用填充凝胶的毛细管中的高温进行分离,然后进行激光检测。使用AS-PCR在42/191(22.0%)的样本中发现了KRAS基因突变,使用TTGE在62/191(32.5%)的样本中发现了KRAS基因突变,而使用CDCE在66/191(34.6%)的样本中发现了KRAS基因突变。在TTGE和CDCE分析中,通过将电泳图谱与已知突变的电泳图谱进行比较或在重新分析之前将样品与已知突变进行混合,来确定突变体的序列。在PCR之前混合突变和野生型等位基因的滴定实验中,对于TTGE,突变检测的灵敏度显示为10(-2),对于CDCE,在优化条件下,突变检测的灵敏度为10(-3)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号